The Novel NF-κB Inhibitor, Dehydroxymethylepoxyquinomicin, Prevents Local and Remote Organ Injury Following Intestinal Ischemia/Reperfusion in Rats
- 1 September 2008
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 149 (1) , 69-75
- https://doi.org/10.1016/j.jss.2008.01.020
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- NF‐κB plays a major role during the systemic and local acute inflammatory response following intestinal reperfusion injuryBritish Journal of Pharmacology, 2005
- Lung Injury After Intestinal Ischemia?Reperfusion May Be Avoided by the Reduced Absorption of Locally Produced CytokinesSurgery Today, 2004
- Inhibition of Tumor Necrosis Factor-α-induced Nuclear Translocation and Activation of NF-κB by DehydroxymethylepoxyquinomicinPublished by Elsevier ,2002
- FK409 inhibits both local and remote organ damage after intestinal ischaemiaThe Journal of Pathology, 2002
- ACTIVATION OF NF-κB VARIES IN DIFFERENT REGIONS OF THE GASTROINTESTINAL TRACT DURING ENDOTOXEMIAShock, 2000
- Synthesis of NF-κB activation inhibitors derived from epoxyquinomicin CBioorganic & Medicinal Chemistry Letters, 2000
- Lipopolysaccharide activates nuclear factor κB in rat intestine: role of endogenous platelet‐activating factor and tumour necrosis factorBritish Journal of Pharmacology, 2000
- An Essential Role for NF-κB in Preventing TNF-α-Induced Cell DeathScience, 1996
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemiaNature, 1987